https://www.selleckchem.com/products/azd6738.html
Multivariate Cox regression analyses revealed L-FABP levels as independent predictors of the primary endpoint (p less then 0.001). Adding L-FABP to a baseline model with established risk factors further enhanced reclassification and discrimination beyond that of the baseline model alone, for primary-endpoint prediction (both; p less then 0.01). On Kaplan-Meier analyses, increased L-FABP (≥4th quintile value of 9.0 ng/mL) on admission or presence of creatinine-defined AKI, correlated with an increased risk of the primary endpoint (p less